Furthermore, studies found that the high expression of visfatin in malignant tissue was able to predict poor prognosis in colon cancer and a high level of visfatin in colorectal cancer patient's serum correlated with poor disease staging [3,28,29]. This evidence concerns the gene NAMPT and colonic neoplasm.